CN102435734A - 卵巢癌原发化疗敏感性测评试剂盒及其应用 - Google Patents

卵巢癌原发化疗敏感性测评试剂盒及其应用 Download PDF

Info

Publication number
CN102435734A
CN102435734A CN2011102660411A CN201110266041A CN102435734A CN 102435734 A CN102435734 A CN 102435734A CN 2011102660411 A CN2011102660411 A CN 2011102660411A CN 201110266041 A CN201110266041 A CN 201110266041A CN 102435734 A CN102435734 A CN 102435734A
Authority
CN
China
Prior art keywords
minutes
sample
ovarian cancer
former
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011102660411A
Other languages
English (en)
Chinese (zh)
Inventor
崔世英
丁艳芳
赵瑾瑶
杨亮
毕丽华
姜继勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian Medical University
Original Assignee
Dalian Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian Medical University filed Critical Dalian Medical University
Priority to CN2011102660411A priority Critical patent/CN102435734A/zh
Priority to PCT/CN2011/079885 priority patent/WO2013033933A1/fr
Publication of CN102435734A publication Critical patent/CN102435734A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN2011102660411A 2011-09-08 2011-09-08 卵巢癌原发化疗敏感性测评试剂盒及其应用 Pending CN102435734A (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN2011102660411A CN102435734A (zh) 2011-09-08 2011-09-08 卵巢癌原发化疗敏感性测评试剂盒及其应用
PCT/CN2011/079885 WO2013033933A1 (fr) 2011-09-08 2011-09-20 Trousse, procédé et utilisation pour mesurer et évaluer la sensibilité du cancer de l'ovaire à une chimiothérapie primaire

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011102660411A CN102435734A (zh) 2011-09-08 2011-09-08 卵巢癌原发化疗敏感性测评试剂盒及其应用

Publications (1)

Publication Number Publication Date
CN102435734A true CN102435734A (zh) 2012-05-02

Family

ID=45983897

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011102660411A Pending CN102435734A (zh) 2011-09-08 2011-09-08 卵巢癌原发化疗敏感性测评试剂盒及其应用

Country Status (2)

Country Link
CN (1) CN102435734A (fr)
WO (1) WO2013033933A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106198996A (zh) * 2016-06-29 2016-12-07 大连医科大学 微小病变型肾病的早期诊断生物标记物、试剂盒及其应用
CN106610434A (zh) * 2016-02-26 2017-05-03 弗雷米德生物医药技术（天津）有限公司 一种hpv16型e7蛋白的elisa检测试剂盒
CN113774135A (zh) * 2021-09-17 2021-12-10 广东省人民医院 一组用于预测高级别浆液性卵巢癌预后的标志物及其应用
CN117741149A (zh) * 2024-02-19 2024-03-22 卡秋(江苏)生物科技有限公司 一种用于卵巢癌细胞叶酸受体α的检测试剂盒及其应用

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007028161A2 (fr) * 2005-09-02 2007-03-08 The University Of Toledo Procédés et compositions permettant d’identifier des biomarqueurs utiles au diagnostic et/ou au traitement d’états biologiques
US20080026950A1 (en) * 2004-02-24 2008-01-31 Mitsubishi Rayon Co., Ltd. Gene Relating to Estimation of Postoperative Prognosis for Breast Cancer
CN101153325A (zh) * 2006-09-28 2008-04-02 上海主健生物工程有限公司 通过ERCC2等基因的SNPs检测肺癌易感性的试剂盒
CN101306158A (zh) * 2007-05-14 2008-11-19 河北以岭医药研究院有限公司 一种中药组合物在制备治疗心肌梗死的药物中的应用
CN101354341A (zh) * 2007-07-27 2009-01-28 上海主健生物工程有限公司 检测女性肿瘤疾病遗传易感性的试剂盒
CN101371261A (zh) * 2005-11-14 2009-02-18 纽约哥伦比亚大学理事会 神经发生的mri成像相关方法
CN101598731A (zh) * 2009-05-07 2009-12-09 陈志南 一种用于肿瘤病理诊断用途的免疫组织化学诊断试剂盒

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080026950A1 (en) * 2004-02-24 2008-01-31 Mitsubishi Rayon Co., Ltd. Gene Relating to Estimation of Postoperative Prognosis for Breast Cancer
WO2007028161A2 (fr) * 2005-09-02 2007-03-08 The University Of Toledo Procédés et compositions permettant d’identifier des biomarqueurs utiles au diagnostic et/ou au traitement d’états biologiques
CN101371261A (zh) * 2005-11-14 2009-02-18 纽约哥伦比亚大学理事会 神经发生的mri成像相关方法
CN101153325A (zh) * 2006-09-28 2008-04-02 上海主健生物工程有限公司 通过ERCC2等基因的SNPs检测肺癌易感性的试剂盒
CN101306158A (zh) * 2007-05-14 2008-11-19 河北以岭医药研究院有限公司 一种中药组合物在制备治疗心肌梗死的药物中的应用
CN101354341A (zh) * 2007-07-27 2009-01-28 上海主健生物工程有限公司 检测女性肿瘤疾病遗传易感性的试剂盒
CN101598731A (zh) * 2009-05-07 2009-12-09 陈志南 一种用于肿瘤病理诊断用途的免疫组织化学诊断试剂盒

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
LIN K, YE D, XIE X: "Protein expression levels of excision repair cross-complementation group 1 and xeroderma pigmentosum D correlate with response to platinum-based chemotherapy in the patients with advanced epithelial ovarian cancer", 《INT J GYNECOL CANCER》 *
候旭等: "MGMT、ERCC2基因对替莫唑胺治疗恶性胶质瘤耐药性的影响极其表达相关性", 《中华医学杂志》 *
夏婷等: "切除修复交叉互补基因1（ERCC1）在卵巢癌中的研究进展", 《肿瘤学杂志》 *
汤春辉等: "卵巢癌实体瘤ERCC2表达与肿瘤发生及耐药的关系", 《肿瘤研究与临床》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106610434A (zh) * 2016-02-26 2017-05-03 弗雷米德生物医药技术（天津）有限公司 一种hpv16型e7蛋白的elisa检测试剂盒
CN106198996A (zh) * 2016-06-29 2016-12-07 大连医科大学 微小病变型肾病的早期诊断生物标记物、试剂盒及其应用
CN113774135A (zh) * 2021-09-17 2021-12-10 广东省人民医院 一组用于预测高级别浆液性卵巢癌预后的标志物及其应用
CN113774135B (zh) * 2021-09-17 2024-03-08 广东省人民医院 一组用于预测高级别浆液性卵巢癌预后的标志物及其应用
CN117741149A (zh) * 2024-02-19 2024-03-22 卡秋(江苏)生物科技有限公司 一种用于卵巢癌细胞叶酸受体α的检测试剂盒及其应用

Also Published As

Publication number Publication date
WO2013033933A1 (fr) 2013-03-14

Similar Documents

Publication Publication Date Title
Decenzo et al. Antigenic deletion and prognosis of patients with stage A transitional cell bladder carcinoma
Swan et al. Bone marrow core biopsy specimens in AL (primary) amyloidosis: a morphologic and immunohistochemical study of 100 cases
Uy et al. Breast cancer hormone receptor assay results of core needle biopsy and modified radical mastectomy specimens from the same patients
KR20140019833A (ko) 유방암의 바이오마커
Shimizu et al. Proliferative activity of human thyroid tumors evaluated by proliferating cell nuclear antigen/cyclin immunohistochemical studies
CN101105496A (zh) 通过同时测量至少两种不同分子标记物来提高检测肿瘤及其前体阶段时的临床特异性的方法
US11292851B2 (en) Synthetic peptide, relative artificial antigen, relative anti-EHD2 antibody and preparation method thereof and use thereof
CN105368853A (zh) 一种与非小细胞肺癌辅助诊断相关的标志物及其应用
Shi et al. Application of GATA 3 and TTF‐1 in differentiating parathyroid and thyroid nodules on cytology specimens
CN102435734A (zh) 卵巢癌原发化疗敏感性测评试剂盒及其应用
CN109187977A (zh) 一种检测her2抗原不同位点的免疫荧光试剂盒及应用
Gantumur et al. Hepatic stellate cell as a Mac‐2‐binding protein‐producing cell in patients with liver fibrosis
CN111766385A (zh) 术中快速鉴别肺癌和硬化性肺细胞瘤的免疫组化试剂盒
CN108398556A (zh) 用于肝癌切除术后预后的双抗体联合荧光检测试剂盒
CN106198996B (zh) 微小病变型肾病的早期诊断生物标记物、试剂盒及其应用
CN102803968A (zh) 食道癌标志物
CN108957004B (zh) 检测H3K9me2和H3K36me3表达量的试剂在制备胃癌预后评估试剂盒中的应用
TWI512294B (zh) 偵測致死系統之方法與組合物及其用途
CN106706915A (zh) Susd2在制备高级别浆液性卵巢癌诊断和/或预后判断的试剂盒中的应用
CN109870579B (zh) 单克隆抗体保护液及制备方法和应用、应用单克隆抗体保护液的试剂与免疫组化试剂盒
CN109709333B (zh) H4k20、h3k9及h3k36三甲基化量检测试剂在食管癌预后评估中的应用
CN110139656A (zh) 作为膀胱癌的生物标志物的角蛋白17
CN103743906B (zh) 用于测定造血干细胞移植后患者骨髓微环境的试剂盒、系统及方法
CN106841622B (zh) Scml2在诊断胃肠胰神经内分泌肿瘤中的应用
Kirkels et al. Soft agar culture of human transitional cell carcinoma colonies from urine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120502